The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

MLA

Gary S. Firestein, et al. “The JAK Inhibitor CP-690,550 (Tofacitinib) Inhibits TNF-Induced Chemokine Expression in Fibroblast-like Synoviocytes: Autocrine Role of Type I Interferon.” Annals of the Rheumatic Diseases, vol. 71, no. 3, Nov. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5004d9ec3d5e98554e0587ca542dc2a&authtype=sso&custid=ns315887.

APA

Gary S. Firestein, David L. Boyle, Sanna Rosengren, & Maripat Corr. (2011). The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Annals of the Rheumatic Diseases, 71(3).

Chicago

Gary S. Firestein, David L. Boyle, Sanna Rosengren, and Maripat Corr. 2011. “The JAK Inhibitor CP-690,550 (Tofacitinib) Inhibits TNF-Induced Chemokine Expression in Fibroblast-like Synoviocytes: Autocrine Role of Type I Interferon.” Annals of the Rheumatic Diseases 71 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d5004d9ec3d5e98554e0587ca542dc2a&authtype=sso&custid=ns315887.